Home > > > Report Detail

Global Genomics Personalized Health Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 09-Nov-2022
No. of pages: 150
Inquire Before Buying

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Genomics Personalized Health companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Genomics Personalized Health market. Further, it explains the major drivers and regional dynamics of the global Genomics Personalized Health market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- QIAGEN

- Illumina

- Thermo Fisher Scientific

- Bio-Rad

- Roche

- Lonza

- INVITAE

- Genetic Technologies

- Interleukin Genetics

- Eastern Biotech

- DNA Genotek

- UBiome

- XCode Life

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Genomics Personalized Health Segment by Type

- NGS Platforms

- RT-PCR

- Microarray

- Genetic Analyzers

Genomics Personalized Health Segment by Application

- Academics & Research Institutes

- Diagnostic Centers

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Genomics Personalized Health market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Genomics Personalized Health market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Genomics Personalized Health, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Genomics Personalized Health, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Genomics Personalized Health revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Genomics Personalized Health market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Genomics Personalized Health revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including QIAGEN, Illumina, Thermo Fisher Scientific, Bio-Rad, Roche, Lonza, INVITAE, Genetic Technologies and Interleukin Genetics, etc.

Global Genomics Personalized Health Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genomics Personalized Health Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 NGS Platforms
1.2.3 RT-PCR
1.2.4 Microarray
1.2.5 Genetic Analyzers
1.3 Market by Application
1.3.1 Global Genomics Personalized Health Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Academics & Research Institutes
1.3.3 Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Genomics Personalized Health Market Size (2017-2028)
2.2 Genomics Personalized Health Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Genomics Personalized Health Market Size by Region (2017-2022)
2.4 Global Genomics Personalized Health Market Size Forecast by Region (2023-2028)
2.5 Global Top Genomics Personalized Health Countries Ranking by Market Size
3 Genomics Personalized Health Competitive by Company
3.1 Global Genomics Personalized Health Revenue by Players
3.1.1 Global Genomics Personalized Health Revenue by Players (2017-2022)
3.1.2 Global Genomics Personalized Health Market Share by Players (2017-2022)
3.2 Global Genomics Personalized Health Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Genomics Personalized Health Revenue
3.4 Global Genomics Personalized Health Market Concentration Ratio
3.4.1 Global Genomics Personalized Health Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genomics Personalized Health Revenue in 2021
3.5 Global Genomics Personalized Health Key Players Head office and Area Served
3.6 Key Players Genomics Personalized Health Product Solution and Service
3.7 Date of Enter into Genomics Personalized Health Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Genomics Personalized Health Breakdown Data by Type
4.1 Global Genomics Personalized Health Historic Revenue by Type (2017-2022)
4.2 Global Genomics Personalized Health Forecasted Revenue by Type (2023-2028)
5 Global Genomics Personalized Health Breakdown Data by Application
5.1 Global Genomics Personalized Health Historic Market Size by Application (2017-2022)
5.2 Global Genomics Personalized Health Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Genomics Personalized Health Revenue by Company (2020-2022)
6.2 North America Genomics Personalized Health Revenue by Type (2017-2028)
6.3 North America Genomics Personalized Health Revenue by Application (2017-2028)
6.4 North America Genomics Personalized Health Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Genomics Personalized Health Revenue by Company (2020-2022)
7.2 Europe Genomics Personalized Health Revenue by Type (2017-2028)
7.3 Europe Genomics Personalized Health Revenue by Application (2017-2028)
7.4 Europe Genomics Personalized Health Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Genomics Personalized Health Revenue by Company (2020-2022)
8.2 Asia Pacific Genomics Personalized Health Revenue by Type (2017-2028)
8.3 Asia Pacific Genomics Personalized Health Revenue by Application (2017-2028)
8.4 Asia Pacific Genomics Personalized Health Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Genomics Personalized Health Revenue by Company (2020-2022)
9.2 Latin America Genomics Personalized Health Revenue by Type (2017-2028)
9.3 Latin America Genomics Personalized Health Revenue by Application (2017-2028)
9.4 Latin America Genomics Personalized Health Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Genomics Personalized Health Revenue by Company (2020-2022)
10.2 Middle East and Africa Genomics Personalized Health Revenue by Type (2017-2028)
10.3 Middle East and Africa Genomics Personalized Health Revenue by Application (2017-2028)
10.4 Middle East and Africa Genomics Personalized Health Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 QIAGEN
11.1.1 QIAGEN Company Details
11.1.2 QIAGEN Business Overview
11.1.3 QIAGEN Genomics Personalized Health Products and Services
11.1.4 QIAGEN Genomics Personalized Health Revenue in Genomics Personalized Health Business (2017-2022)
11.1.5 QIAGEN Genomics Personalized Health SWOT Analysis
11.1.6 QIAGEN Recent Developments
11.2 Illumina
11.2.1 Illumina Company Details
11.2.2 Illumina Business Overview
11.2.3 Illumina Genomics Personalized Health Products and Services
11.2.4 Illumina Genomics Personalized Health Revenue in Genomics Personalized Health Business (2017-2022)
11.2.5 Illumina Genomics Personalized Health SWOT Analysis
11.2.6 Illumina Recent Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Genomics Personalized Health Products and Services
11.3.4 Thermo Fisher Scientific Genomics Personalized Health Revenue in Genomics Personalized Health Business (2017-2022)
11.3.5 Thermo Fisher Scientific Genomics Personalized Health SWOT Analysis
11.3.6 Thermo Fisher Scientific Recent Developments
11.4 Bio-Rad
11.4.1 Bio-Rad Company Details
11.4.2 Bio-Rad Business Overview
11.4.3 Bio-Rad Genomics Personalized Health Products and Services
11.4.4 Bio-Rad Genomics Personalized Health Revenue in Genomics Personalized Health Business (2017-2022)
11.4.5 Bio-Rad Genomics Personalized Health SWOT Analysis
11.4.6 Bio-Rad Recent Developments
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Genomics Personalized Health Products and Services
11.5.4 Roche Genomics Personalized Health Revenue in Genomics Personalized Health Business (2017-2022)
11.5.5 Roche Genomics Personalized Health SWOT Analysis
11.5.6 Roche Recent Developments
11.6 Lonza
11.6.1 Lonza Company Details
11.6.2 Lonza Business Overview
11.6.3 Lonza Genomics Personalized Health Products and Services
11.6.4 Lonza Genomics Personalized Health Revenue in Genomics Personalized Health Business (2017-2022)
11.6.5 Lonza Genomics Personalized Health SWOT Analysis
11.6.6 Lonza Recent Developments
11.7 INVITAE
11.7.1 INVITAE Company Details
11.7.2 INVITAE Business Overview
11.7.3 INVITAE Genomics Personalized Health Products and Services
11.7.4 INVITAE Genomics Personalized Health Revenue in Genomics Personalized Health Business (2017-2022)
11.7.5 INVITAE Genomics Personalized Health SWOT Analysis
11.7.6 INVITAE Recent Developments
11.8 Genetic Technologies
11.8.1 Genetic Technologies Company Details
11.8.2 Genetic Technologies Business Overview
11.8.3 Genetic Technologies Genomics Personalized Health Products and Services
11.8.4 Genetic Technologies Genomics Personalized Health Revenue in Genomics Personalized Health Business (2017-2022)
11.8.5 Genetic Technologies Genomics Personalized Health SWOT Analysis
11.8.6 Genetic Technologies Recent Developments
11.9 Interleukin Genetics
11.9.1 Interleukin Genetics Company Details
11.9.2 Interleukin Genetics Business Overview
11.9.3 Interleukin Genetics Genomics Personalized Health Products and Services
11.9.4 Interleukin Genetics Genomics Personalized Health Revenue in Genomics Personalized Health Business (2017-2022)
11.9.5 Interleukin Genetics Genomics Personalized Health SWOT Analysis
11.9.6 Interleukin Genetics Recent Developments
11.10 Eastern Biotech
11.10.1 Eastern Biotech Company Details
11.10.2 Eastern Biotech Business Overview
11.10.3 Eastern Biotech Genomics Personalized Health Products and Services
11.10.4 Eastern Biotech Genomics Personalized Health Revenue in Genomics Personalized Health Business (2017-2022)
11.10.5 Eastern Biotech Genomics Personalized Health SWOT Analysis
11.10.6 Eastern Biotech Recent Developments
11.11 DNA Genotek
11.11.1 DNA Genotek Company Details
11.11.2 DNA Genotek Business Overview
11.11.3 DNA Genotek Genomics Personalized Health Products and Services
11.11.4 DNA Genotek Genomics Personalized Health Revenue in Genomics Personalized Health Business (2017-2022)
11.11.5 DNA Genotek Recent Developments
11.12 UBiome
11.12.1 UBiome Company Details
11.12.2 UBiome Business Overview
11.12.3 UBiome Genomics Personalized Health Products and Services
11.12.4 UBiome Genomics Personalized Health Revenue in Genomics Personalized Health Business (2017-2022)
11.12.5 UBiome Recent Developments
11.13 XCode Life
11.13.1 XCode Life Company Details
11.13.2 XCode Life Business Overview
11.13.3 XCode Life Genomics Personalized Health Products and Services
11.13.4 XCode Life Genomics Personalized Health Revenue in Genomics Personalized Health Business (2017-2022)
11.13.5 XCode Life Recent Developments
12 Genomics Personalized Health Market Dynamics
12.1 Genomics Personalized Health Market Trends
12.2 Genomics Personalized Health Market Drivers
12.3 Genomics Personalized Health Market Challenges
12.4 Genomics Personalized Health Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global Genomics Personalized Health Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of NGS Platforms
Table 3. Key Players of RT-PCR
Table 4. Key Players of Microarray
Table 5. Key Players of Genetic Analyzers
Table 6. Global Genomics Personalized Health Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Genomics Personalized Health Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 8. Global Genomics Personalized Health Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Genomics Personalized Health Revenue Market Share by Region (2017-2022)
Table 10. Global Genomics Personalized Health Revenue by Players (2017-2022) & (US$ Million)
Table 11. Global Genomics Personalized Health Market Share by Players (2017-2022)
Table 12. Global Top Genomics Personalized Health Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomics Personalized Health as of 2021)
Table 13. Ranking of Global Top Genomics Personalized Health Companies by Revenue (US$ Million) in 2021
Table 14. Global 5 Largest Players Market Share by Genomics Personalized Health Revenue (CR5 and HHI) & (2017-2022)
Table 15. Key Players Headquarters and Area Served
Table 16. Key Players Genomics Personalized Health Product Solution and Service
Table 17. Date of Key Manufacturers Enter into Genomics Personalized Health Market
Table 18. Mergers & Acquisitions, Expansion Plans
Table 19. Global Genomics Personalized Health Market Size by Type (2017-2022) & (US$ Million)
Table 20. Global Genomics Personalized Health Revenue Market Share by Type (2017-2022)
Table 21. Global Genomics Personalized Health Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 22. Global Genomics Personalized Health Revenue Market Share by Type (2023-2028)
Table 23. Global Genomics Personalized Health Market Size by Application (2017-2022) & (US$ Million)
Table 24. Global Genomics Personalized Health Revenue Market Share by Application (2017-2022)
Table 25. Global Genomics Personalized Health Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 26. Global Genomics Personalized Health Revenue Market Share by Application (2023-2028)
Table 27. North America Genomics Personalized Health Revenue by Company (2020-2022) & (US$ Million)
Table 28. North America Genomics Personalized Health Revenue by Type (2017-2022) & (US$ Million)
Table 29. North America Genomics Personalized Health Revenue by Type (2023-2028) & (US$ Million)
Table 30. North America Genomics Personalized Health Revenue by Application (2017-2022) & (US$ Million)
Table 31. North America Genomics Personalized Health Revenue by Application (2023-2028) & (US$ Million)
Table 32. North America Genomics Personalized Health Revenue by Country (2017-2022) & (US$ Million)
Table 33. North America Genomics Personalized Health Revenue by Country (2023-2028) & (US$ Million)
Table 34. Europe Genomics Personalized Health Revenue by Company (2020-2022) & (US$ Million)
Table 35. Europe Genomics Personalized Health Revenue by Type (2017-2022) & (US$ Million)
Table 36. Europe Genomics Personalized Health Revenue by Type (2023-2028) & (US$ Million)
Table 37. Europe Genomics Personalized Health Revenue by Application (2017-2022) & (US$ Million)
Table 38. Europe Genomics Personalized Health Revenue by Application (2023-2028) & (US$ Million)
Table 39. Europe Genomics Personalized Health Revenue by Country (2017-2022) & (US$ Million)
Table 40. Europe Genomics Personalized Health Revenue by Country (2023-2028) & (US$ Million)
Table 41. Asia Pacific Genomics Personalized Health Revenue by Company (2020-2022) & (US$ Million)
Table 42. Asia Pacific Genomics Personalized Health Revenue by Type (2017-2022) & (US$ Million)
Table 43. Asia Pacific Genomics Personalized Health Revenue by Type (2023-2028) & (US$ Million)
Table 44. Asia Pacific Genomics Personalized Health Revenue by Application (2017-2022) & (US$ Million)
Table 45. Asia Pacific Genomics Personalized Health Revenue by Application (2023-2028) & (US$ Million)
Table 46. Asia Pacific Genomics Personalized Health Revenue by Region (2017-2022) & (US$ Million)
Table 47. Asia Pacific Genomics Personalized Health Revenue by Region (2023-2028) & (US$ Million)
Table 48. Latin America Genomics Personalized Health Revenue by Company (2020-2022) & (US$ Million)
Table 49. Latin America Genomics Personalized Health Revenue by Type (2017-2022) & (US$ Million)
Table 50. Latin America Genomics Personalized Health Revenue by Type (2023-2028) & (US$ Million)
Table 51. Latin America Genomics Personalized Health Revenue by Application (2017-2022) & (US$ Million)
Table 52. Latin America Genomics Personalized Health Revenue by Application (2023-2028) & (US$ Million)
Table 53. Latin America Genomics Personalized Health Revenue by Country (2017-2022) & (US$ Million)
Table 54. Latin America Genomics Personalized Health Revenue by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Genomics Personalized Health Revenue by Company (2020-2022) & (US$ Million)
Table 56. Middle East and Africa Genomics Personalized Health Revenue by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Genomics Personalized Health Revenue by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Genomics Personalized Health Revenue by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Genomics Personalized Health Revenue by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Genomics Personalized Health Revenue by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Genomics Personalized Health Revenue by Country (2023-2028) & (US$ Million)
Table 62. QIAGEN Company Details
Table 63. QIAGEN Business Overview
Table 64. QIAGEN Genomics Personalized Health Product and Services
Table 65. QIAGEN Genomics Personalized Health Revenue in Genomics Personalized Health Business (2017-2022) & (US$ Million)
Table 66. QIAGEN Genomics Personalized Health SWOT Analysis
Table 67. QIAGEN Recent Developments
Table 68. Illumina Company Details
Table 69. Illumina Business Overview
Table 70. Illumina Genomics Personalized Health Product and Services
Table 71. Illumina Genomics Personalized Health Revenue in Genomics Personalized Health Business (2017-2022) & (US$ Million)
Table 72. Illumina Genomics Personalized Health SWOT Analysis
Table 73. Illumina Recent Developments
Table 74. Thermo Fisher Scientific Company Details
Table 75. Thermo Fisher Scientific Business Overview
Table 76. Thermo Fisher Scientific Genomics Personalized Health Product and Services
Table 77. Thermo Fisher Scientific Genomics Personalized Health Revenue in Genomics Personalized Health Business (2017-2022) & (US$ Million)
Table 78. Thermo Fisher Scientific Genomics Personalized Health SWOT Analysis
Table 79. Thermo Fisher Scientific Recent Developments
Table 80. Bio-Rad Company Details
Table 81. Bio-Rad Business Overview
Table 82. Bio-Rad Genomics Personalized Health Product and Services
Table 83. Bio-Rad Genomics Personalized Health Revenue in Genomics Personalized Health Business (2017-2022) & (US$ Million)
Table 84. Bio-Rad Genomics Personalized Health SWOT Analysis
Table 85. Bio-Rad Recent Developments
Table 86. Roche Company Details
Table 87. Roche Business Overview
Table 88. Roche Genomics Personalized Health Product and Services
Table 89. Roche Genomics Personalized Health Revenue in Genomics Personalized Health Business (2017-2022) & (US$ Million)
Table 90. Roche Genomics Personalized Health SWOT Analysis
Table 91. Roche Recent Developments
Table 92. Lonza Company Details
Table 93. Lonza Business Overview
Table 94. Lonza Genomics Personalized Health Product and Services
Table 95. Lonza Genomics Personalized Health Revenue in Genomics Personalized Health Business (2017-2022) & (US$ Million)
Table 96. Lonza Genomics Personalized Health SWOT Analysis
Table 97. Lonza Recent Developments
Table 98. INVITAE Company Details
Table 99. INVITAE Business Overview
Table 100. INVITAE Genomics Personalized Health Product and Services
Table 101. INVITAE Genomics Personalized Health Revenue in Genomics Personalized Health Business (2017-2022) & (US$ Million)
Table 102. INVITAE Genomics Personalized Health SWOT Analysis
Table 103. INVITAE Recent Developments
Table 104. Genetic Technologies Company Details
Table 105. Genetic Technologies Business Overview
Table 106. Genetic Technologies Genomics Personalized Health Product and Services
Table 107. Genetic Technologies Genomics Personalized Health Revenue in Genomics Personalized Health Business (2017-2022) & (US$ Million)
Table 108. Genetic Technologies Genomics Personalized Health SWOT Analysis
Table 109. Genetic Technologies Recent Developments
Table 110. Interleukin Genetics Company Details
Table 111. Interleukin Genetics Business Overview
Table 112. Interleukin Genetics Genomics Personalized Health Product and Services
Table 113. Interleukin Genetics Genomics Personalized Health Revenue in Genomics Personalized Health Business (2017-2022) & (US$ Million)
Table 114. Interleukin Genetics Genomics Personalized Health SWOT Analysis
Table 115. Interleukin Genetics Recent Developments
Table 116. Eastern Biotech Company Details
Table 117. Eastern Biotech Business Overview
Table 118. Eastern Biotech Genomics Personalized Health Product and Services
Table 119. Eastern Biotech Genomics Personalized Health Revenue in Genomics Personalized Health Business (2017-2022) & (US$ Million)
Table 120. Eastern Biotech Genomics Personalized Health SWOT Analysis
Table 121. Eastern Biotech Recent Developments
Table 122. DNA Genotek Company Details
Table 123. DNA Genotek Business Overview
Table 124. DNA Genotek Genomics Personalized Health Product and Services
Table 125. DNA Genotek Genomics Personalized Health Revenue in Genomics Personalized Health Business (2017-2022) & (US$ Million)
Table 126. DNA Genotek Recent Developments
Table 127. UBiome Company Details
Table 128. UBiome Business Overview
Table 129. UBiome Genomics Personalized Health Product and Services
Table 130. UBiome Genomics Personalized Health Revenue in Genomics Personalized Health Business (2017-2022) & (US$ Million)
Table 131. UBiome Recent Developments
Table 132. XCode Life Company Details
Table 133. XCode Life Business Overview
Table 134. XCode Life Genomics Personalized Health Product and Services
Table 135. XCode Life Genomics Personalized Health Revenue in Genomics Personalized Health Business (2017-2022) & (US$ Million)
Table 136. XCode Life Recent Developments
Table 137. Genomics Personalized Health Market Trends
Table 138. Genomics Personalized Health Market Drivers
Table 139. Genomics Personalized Health Market Challenges
Table 140. Genomics Personalized Health Market Restraints
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Genomics Personalized Health Sales Market Share by Type: 2021 VS 2028
Figure 2. NGS Platforms Features
Figure 3. RT-PCR Features
Figure 4. Microarray Features
Figure 5. Genetic Analyzers Features
Figure 6. Global Genomics Personalized Health Sales Market Share by Application: 2021 VS 2028
Figure 7. Academics & Research Institutes Case Studies
Figure 8. Diagnostic Centers Case Studies
Figure 9. Genomics Personalized Health Report Years Considered
Figure 10. Global Genomics Personalized Health Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Genomics Personalized Health Market Size 2017-2028 (US$ Million)
Figure 12. Global Genomics Personalized Health Market Size Market Share by Region: 2021 VS 2028
Figure 13. Global Genomics Personalized Health Revenue Market Share by Region in 2017 VS 2022
Figure 14. Global Top 10 Genomics Personalized Health Countries Ranking by Market Size (US$ Million) in 2021
Figure 15. Global Genomics Personalized Health Market Share by Players in 2021
Figure 16. Global Top Genomics Personalized Health Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomics Personalized Health as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Genomics Personalized Health Revenue in 2021
Figure 18. North America Genomics Personalized Health Revenue Market Share by Company in 2021
Figure 19. North America Genomics Personalized Health Revenue Market Share by Type (2017-2028)
Figure 20. North America Genomics Personalized Health Revenue Market Share by Application (2017-2028)
Figure 21. North America Genomics Personalized Health Revenue Share by Country (2017-2028)
Figure 22. U.S. Genomics Personalized Health Revenue (2017-2028) & (US$ Million)
Figure 23. Canada Genomics Personalized Health Revenue (2017-2028) & (US$ Million)
Figure 24. Europe Genomics Personalized Health Revenue Market Share by Company in 2021
Figure 25. Europe Genomics Personalized Health Revenue Market Share by Type (2017-2028)
Figure 26. Europe Genomics Personalized Health Revenue Market Share by Application (2017-2028)
Figure 27. Europe Genomics Personalized Health Revenue Share by Country (2017-2028)
Figure 28. Germany Genomics Personalized Health Revenue (2017-2028) & (US$ Million)
Figure 29. France Genomics Personalized Health Revenue (2017-2028) & (US$ Million)
Figure 30. U.K. Genomics Personalized Health Revenue (2017-2028) & (US$ Million)
Figure 31. Italy Genomics Personalized Health Revenue (2017-2028) & (US$ Million)
Figure 32. Russia Genomics Personalized Health Revenue (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Genomics Personalized Health Revenue Market Share by Company in 2021
Figure 34. Asia Pacific Genomics Personalized Health Revenue Market Share by Type (2017-2028)
Figure 35. Asia Pacific Genomics Personalized Health Revenue Market Share by Application (2017-2028)
Figure 36. Asia Pacific Genomics Personalized Health Revenue Share by Region (2017-2028)
Figure 37. China Genomics Personalized Health Revenue (2017-2028) & (US$ Million)
Figure 38. Japan Genomics Personalized Health Revenue (2017-2028) & (US$ Million)
Figure 39. South Korea Genomics Personalized Health Revenue (2017-2028) & (US$ Million)
Figure 40. India Genomics Personalized Health Revenue (2017-2028) & (US$ Million)
Figure 41. Australia Genomics Personalized Health Revenue (2017-2028) & (US$ Million)
Figure 42. Taiwan Genomics Personalized Health Revenue (2017-2028) & (US$ Million)
Figure 43. Indonesia Genomics Personalized Health Revenue (2017-2028) & (US$ Million)
Figure 44. Thailand Genomics Personalized Health Revenue (2017-2028) & (US$ Million)
Figure 45. Malaysia Genomics Personalized Health Revenue (2017-2028) & (US$ Million)
Figure 46. Philippines Genomics Personalized Health Revenue (2017-2028) & (US$ Million)
Figure 47. Vietnam Genomics Personalized Health Revenue (2017-2028) & (US$ Million)
Figure 48. Latin America Genomics Personalized Health Revenue Market Share by Company in 2021
Figure 49. Latin America Genomics Personalized Health Revenue Market Share by Type (2017-2028)
Figure 50. Latin America Genomics Personalized Health Revenue Market Share by Application (2017-2028)
Figure 51. Latin America Genomics Personalized Health Revenue Share by Country (2017-2028)
Figure 52. Mexico Genomics Personalized Health Revenue (2017-2028) & (US$ Million)
Figure 53. Brazil Genomics Personalized Health Revenue (2017-2028) & (US$ Million)
Figure 54. Argentina Genomics Personalized Health Revenue (2017-2028) & (US$ Million)
Figure 55. Middle East and Africa Genomics Personalized Health Revenue Market Share by Company in 2021
Figure 56. Middle East and Africa Genomics Personalized Health Revenue Market Share by Type (2017-2028)
Figure 57. Middle East and Africa Genomics Personalized Health Revenue Market Share by Application (2017-2028)
Figure 58. Middle East and Africa Genomics Personalized Health Revenue Share by Country (2017-2028)
Figure 59. Turkey Genomics Personalized Health Revenue (2017-2028) & (US$ Million)
Figure 60. Saudi Arabia Genomics Personalized Health Revenue (2017-2028) & (US$ Million)
Figure 61. U.A.E Genomics Personalized Health Revenue (2017-2028) & (US$ Million)
Figure 62. QIAGEN Revenue Growth Rate in Genomics Personalized Health Business (2017-2022)
Figure 63. Illumina Revenue Growth Rate in Genomics Personalized Health Business (2017-2022)
Figure 64. Thermo Fisher Scientific Revenue Growth Rate in Genomics Personalized Health Business (2017-2022)
Figure 65. Bio-Rad Revenue Growth Rate in Genomics Personalized Health Business (2017-2022)
Figure 66. Roche Revenue Growth Rate in Genomics Personalized Health Business (2017-2022)
Figure 67. Lonza Revenue Growth Rate in Genomics Personalized Health Business (2017-2022)
Figure 68. INVITAE Revenue Growth Rate in Genomics Personalized Health Business (2017-2022)
Figure 69. Genetic Technologies Revenue Growth Rate in Genomics Personalized Health Business (2017-2022)
Figure 70. Interleukin Genetics Revenue Growth Rate in Genomics Personalized Health Business (2017-2022)
Figure 71. Eastern Biotech Revenue Growth Rate in Genomics Personalized Health Business (2017-2022)
Figure 72. DNA Genotek Revenue Growth Rate in Genomics Personalized Health Business (2017-2022)
Figure 73. UBiome Revenue Growth Rate in Genomics Personalized Health Business (2017-2022)
Figure 74. XCode Life Revenue Growth Rate in Genomics Personalized Health Business (2017-2022)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs